Author:
de Andrade Natalia Xavier S.,Adiyaman Suleyman Cem,De Yuksel Bernamir,Ferrari Carla T.,Eldin Abdelwahab Jalal,Saydam Basak Ozgen,Altay Canan,Sharma Pratima,Bhave Nicole,Little Ann,McKeever Paul,Onay Huseyin,Ozkal Sermin,Secil Mustafa,Yenerel Mustafa Nuri,Akinci Baris,Oral Elif A.
Reference17 articles.
1. Phenotypic and genetic characteristics of lipodystrophy: pathophysiology, metabolic abnormalities, and comorbidities;Akinci;Curr Diab Rep,2018
2. The diagnosis and management of lipodystrophy syndromes: a multi-society practice guideline;Brown;J Clin Endocrinol Metab,2016
3. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy;Oral;Endocrine,2019
4. GoldenJK.Myalept (metreleptin for injection). Clinical Review. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125390Orig1s000MedR.pdf. Accessed February 15, 2020.
5. ColmanEC.Myalept/metreleptin. Summary Review. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/125390Orig1s000SumR.pdf. Accessed February 15, 2020.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献